GOSS logo

Gossamer Bio (GOSS) Cash From Investing

Annual CFI

-$110.97 M
-$109.94 M-10621.74%

December 31, 2023

Summary

Performance

1-Year Change

-10621.74%

3-Year Change

-151.53%

5-Year Change

+23.32%

15-Year Change

-100%

GOSS Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

14.56%
GOSS annual cash flow from investing activities is higher than 14.56% of companies in Healthcare sector

High & Low

All-time High

$215.34 M
GOSS annual cash flow from investing activities is currently -151.53% below its historical high of $215.34 million

3-Year Low

-$117.43 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
GOSS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 5, 2025
GOSS next annual earnings announcement is scheduled for Mar 5, 2025

OtherGOSScash flowmetrics:

Annual CFF

$190.15 M
GOSS annual cash flow from financing activities is $190.15 million

Annual CFO

-$159.16 M
GOSS annual cash flow from operations is -$159.16 million

Annual FCF

-$159.16 M
GOSS annual free cash flow is -$159.16 million

Annual CAPEX

-
GOSS annual capital expenditures value is unknown

Quarterly CFI

-$26.75 M
+$32.36 M+54.74%

September 30, 2024

Summary

Performance

3-Month Change

+54.74%

1-Year Change

-86.23%

3-Year Change

+70.19%

5-Year Change

-249.06%

GOSS Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

15.85%
GOSS quarterly cash flow from investing activities is higher than 15.85% of companies in Healthcare sector

High & Low

All-time High

$106.25 M
GOSS quarterly cash flow from investing activities is currently -125.18% below its historical high of $106.25 million

3-Year Low

-$118.26 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
GOSS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
GOSS next earnings announcement is scheduled for Mar 5, 2025

OtherGOSScash flowmetrics:

Quarterly CFF

$281.00 K
GOSS quarterly cash flow from financing activities is $281.00 thousand

Quarterly CFO

-$32.03 M
GOSS quarterly cash flow from operations is -$32.03 million

Quarterly FCF

-$32.03 M
GOSS quarterly free cash flow is -$32.03 million

Quarterly CAPEX

-
GOSS quarterly capital expenditures value is unknown

TTM CFI

-$38.56 M
+$91.51 M+70.35%

September 30, 2024

Summary

Performance

3-Month Change

+70.35%

1-Year Change

+65.25%

3-Year Change

+42.25%

5-Year Change

+73.8%

GOSS TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.48%
GOSS TTM cash flow from investing activities is higher than 24.48% of companies in Healthcare sector

High & Low

All-time High

$215.34 M
GOSS TTM cash flow from investing activities is currently -117.91% below its historical high of $215.34 million

3-Year Low

-$130.07 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
GOSS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
GOSS next earnings announcement is scheduled for Mar 5, 2025

OtherGOSScash flowmetrics:

TTM CFF

-$14.39 M
GOSS TTM cash flow from financing activities is -$14.39 million

TTM CFO

-$1.41 M
GOSS TTM cash flow from operations is -$1.41 million

TTM FCF

-$1.41 M
GOSS TTM free cash flow is -$1.41 million

TTM CAPEX

-
GOSS TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

GOSS Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10000.0%-86.2%+65.3%
3 y3 years-151.5%+70.2%+42.3%
5 y5 years+23.3%-249.1%+73.8%

GOSS Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%+5.5%-143.4%+77.4%-612.5%+70.3%
5 y5-year-151.5%+24.6%-125.2%+77.4%-117.9%+73.8%
alltimeall time-151.5%+24.6%-125.2%+86.5%-117.9%+89.1%

Gossamer Bio Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$26.75 M(-54.7%)
-$38.56 M(-70.4%)
Jun 2024
-
-$59.11 M(-195.8%)
-$130.07 M(+124.2%)
Mar 2024
-
$61.67 M(-529.3%)
-$58.02 M(-47.7%)
Dec 2023
-$110.97 M(>+9900.0%)
-$14.37 M(-87.9%)
-$110.97 M(+25.9%)
Sep 2023
-
-$118.26 M(-1014.2%)
-$88.14 M(-1271.5%)
Jun 2023
-
$12.94 M(+48.3%)
$7.52 M(-1126.5%)
Mar 2023
-
$8.72 M(+3.0%)
-$733.00 K(-29.2%)
Dec 2022
-$1.03 M(-99.1%)
$8.46 M(-137.5%)
-$1.03 M(-209.6%)
Sep 2022
-
-$22.60 M(-583.0%)
$944.00 K(-101.4%)
Jun 2022
-
$4.68 M(-44.4%)
-$66.22 M(-45.3%)
Mar 2022
-
$8.42 M(-19.4%)
-$120.97 M(+3.0%)
Dec 2021
-$117.43 M
$10.44 M(-111.6%)
-$117.43 M(+75.9%)
Sep 2021
-
-$89.76 M(+79.3%)
-$66.77 M(-255.5%)
Jun 2021
-
-$50.08 M(-518.4%)
$42.95 M(-78.4%)
DateAnnualQuarterlyTTM
Mar 2021
-
$11.97 M(-80.4%)
$199.27 M(-7.5%)
Dec 2020
$215.34 M(-246.3%)
$61.10 M(+206.1%)
$215.34 M(+7.0%)
Sep 2020
-
$19.96 M(-81.2%)
$201.18 M(+1.0%)
Jun 2020
-
$106.25 M(+278.9%)
$199.16 M(+152.0%)
Mar 2020
-
$28.04 M(-40.3%)
$79.04 M(-153.7%)
Dec 2019
-$147.14 M(+1.7%)
$46.93 M(+161.5%)
-$147.14 M(-27.4%)
Sep 2019
-
$17.95 M(-229.3%)
-$202.76 M(-37.8%)
Jun 2019
-
-$13.88 M(-93.0%)
-$325.82 M(-7.8%)
Mar 2019
-
-$198.14 M(+2182.5%)
-$353.52 M(+144.3%)
Dec 2018
-$144.71 M(<-9900.0%)
-$8.68 M(-91.7%)
-$144.71 M(+6.4%)
Sep 2018
-
-$105.12 M(+152.8%)
-$136.03 M(+340.0%)
Jun 2018
-
-$41.58 M(-489.9%)
-$30.91 M(-389.9%)
Mar 2018
-
$10.66 M
$10.66 M
Dec 2017
$0.00(0.0%)
-
-
Dec 2016
$0.00
-
-

FAQ

  • What is Gossamer Bio annual cash flow from investing activities?
  • What is the all time high annual CFI for Gossamer Bio?
  • What is Gossamer Bio annual CFI year-on-year change?
  • What is Gossamer Bio quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Gossamer Bio?
  • What is Gossamer Bio quarterly CFI year-on-year change?
  • What is Gossamer Bio TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Gossamer Bio?
  • What is Gossamer Bio TTM CFI year-on-year change?

What is Gossamer Bio annual cash flow from investing activities?

The current annual CFI of GOSS is -$110.97 M

What is the all time high annual CFI for Gossamer Bio?

Gossamer Bio all-time high annual cash flow from investing activities is $215.34 M

What is Gossamer Bio annual CFI year-on-year change?

Over the past year, GOSS annual cash flow from investing activities has changed by -$109.94 M (-10621.74%)

What is Gossamer Bio quarterly cash flow from investing activities?

The current quarterly CFI of GOSS is -$26.75 M

What is the all time high quarterly CFI for Gossamer Bio?

Gossamer Bio all-time high quarterly cash flow from investing activities is $106.25 M

What is Gossamer Bio quarterly CFI year-on-year change?

Over the past year, GOSS quarterly cash flow from investing activities has changed by -$12.39 M (-86.23%)

What is Gossamer Bio TTM cash flow from investing activities?

The current TTM CFI of GOSS is -$38.56 M

What is the all time high TTM CFI for Gossamer Bio?

Gossamer Bio all-time high TTM cash flow from investing activities is $215.34 M

What is Gossamer Bio TTM CFI year-on-year change?

Over the past year, GOSS TTM cash flow from investing activities has changed by +$72.41 M (+65.25%)